루푸스 환자에서 예방접종

키워드

참고문헌 (43)

1. 정주양, "Infection in systemic lupus erythematosus, similarities, and differences with lupus flare", The Korean Journal of Internal Medicine, 32(3), pp.429~438 (2017), 대한내과학회[DOI]
2. Lee YH, "Overall and cause-specific mortality in systemic lupus erythematosus : an updated meta-analysis", Lupus, 25, pp.727~734 (2016)
3. Bloom DE, "Infectious disease threats in the twenty-first century : strengthening the global response", Front Immunol, 10, pp.549~ (2019)
4. Chang CC, "Effects of annual influenza vaccination on morbidity and mortality in patients with systemic lupus erythematosus : a nationwide cohort study", Sci Rep, 6, pp.37817~ (2016)
5. "National immunization program" (2020)[URL]
6. 최원석, "Revised Adult Immunization Guideline Recommended by the Korean Society of Infectious Diseases, 2014", Infection and Chemotherapy, 47(1), pp.68~79 (2015), 대한감염학회
7. Furer V, "2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases", Ann Rheum Dis, 79, pp.39~52 (2020)
8. Garg M, "Recommendations and barriers to vaccination in systemic lupus erythematosus", Autoimmun Rev, 17, pp.990~1001 (2018)
9. Sang Hoon Han, "Vaccination for Patients with Rheumatic Diseases in the Era of Biologics", 대한류마티스학회지, 25(2), pp.100~107 (2018), 대한류마티스학회[DOI]
10. Wiesik-Szewczyk E, "Anti-influenza vaccination in systemic lupus erythematosus patients : an analysis of specific humoral response and vaccination safety", Clin Rheumatol, 29, pp.605~613 (2010)
11. Huang Y, "Is systemic lupus erythematosus associated with a declined immunogenicity and poor safety of influenza vaccination?: a systematic review and meta-analysis", Medicine (Baltimore), 95, pp.e3637~ (2016)
12. Holvast A, "Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease", Ann Rheum Dis, 65, pp.913~918 (2006)
13. Adler S, "Protective effect of A", H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study, pp.51, 695~700
14. Chatham WW, "Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial", J Rheumatol, 39, pp.1632~1640 (2012)
15. Holvast A, "Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study", Rheumatology (Oxford), 48, pp.1294~1299 (2009)
16. Mathian A, "Factors influencing the efficacy of two injections of a pandemic 2009 influenza A(H1N1)nonadjuvanted vaccine in systemic lupus erythematosus", Arthritis Rheum, 63, pp.3502~3511 (2011)
17. Campos LM, "High disease activity : an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus", Arthritis Care Res(Hoboken)2013;, 65, pp.1121~1127
18. 정청일, "염증류마티스질환에서의 예방접종", 대한류마티스학회지, 20(4), pp.218~222 (2013), 대한류마티스학회
19. Luijten RK, "Serious infections in systemic lupus erythematosus with a focus on pneumococcal infections", Lupus, 23, pp.1512~1516 (2014)
20. Schurder J, "Pneumococcal infection in patients with systemic lupus erythematosus", Joint Bone Spine, 85, pp.333~336 (2018)
21. Rezende RP, "Immunogenicity of pneumococcal polysaccharide vaccine in adult systemic lupus erythematosus patients undergoing immunosuppressive treatment", Lupus, 25, pp.1254~1259 (2016)
22. Nagel J, "Treatment with belimumab in systemic lupus erythematosus does not impair antibody response to 13-valent pneumococcal conjugate vaccine", Lupus, 26, pp.1072~1081 (2017)
23. Matanock A, "Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged ≥65 years : updated recommendations of the advisory committee on immunization practices", MMWR Morb Mortal Wkly Rep, 68, pp.1069~1075 (2019)
24. 신현영, "성인 예방접종의 최신지견", 대한의사협회지, 63(2), pp.128~134 (2020), 대한의사협회
25. Bragazzi NL, "Advances in our understanding of immunization and vaccines for patients with systemic lupus erythematosus", Expert Rev Clin Immunol, 13, pp.939~949 (2017)
26. Battafarano DF, "Antigenspecific antibody responses in lupus patients following immunization", Arthritis Rheum, 41, pp.1828~1834 (1998)
27. Kashef S, "Antigen-specific antibody response in juvenile-onset SLE patients following routine immunization with tetanus toxoid", Iran J Immunol, 5, pp.181~184 (2008)
28. Mertoglu S, "Hepatitis A virus vaccination in childhood-onset systemic lupus erythematosus", Lupus, 28, pp.234~240 (2019)
29. Mok CC, "Herpes zoster vaccination in systemic lupus erythematosus : the current status", Hum Vaccin Immunother, 15, pp.45~48 (2019)
30. Yun H, "Risk of herpes zoster in autoimmune and inflammatory diseases : implications for vaccination", Arthritis Rheumatol, 68, pp.2328~2337 (2016)
31. Kang TY, "Clinical and genetic risk factors of herpes zoster in patients with systemic lupus erythematosus", Rheumatol Int, 25, pp.97~102 (2005)
32. Kawai K, "Risk factors for herpes zoster : a systematic review and meta-analysis", Mayo Clin Proc, 92, pp.1806~1821 (2017)
33. Guthridge JM, "Herpes zoster vaccination in SLE : a pilot study of immunogenicity", J Rheumatol, 40, pp.1875~1880 (2013)
34. Chakravarty EF, "Increased incidence of herpes zoster among patients with systemic lupus erythematosus", Lupus, 22, pp.238~244 (2013)
35. Dooling KL, "Recommendations of the advisory committee on immunization practices for use of herpes zoster vaccines", MMWR Morb Mortal Wkly Rep, 67, pp.103~108 (2018)
36. Lal H, "Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults", N Engl J Med, 372, pp.2087~2096 (2015)
37. Furer V, "Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases(AIIRD) : a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD", RMD Open, 5, pp.e001041~ (2019)
38. 이유현, "Prevalence of Human Papilloma Virus Infections and Cervical Cytological Abnormalities among Korean Women with Systemic Lupus Erythematosus", Journal of Korean Medical Science, 25(10), pp.1431~1437 (2010), 대한의학회
39. Mathian A, "Lupus and vaccinations", Curr Opin Rheumatol, 30, pp.465~470 (2018)
40. Mok CC, "Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus : a case-control study", Ann Rheum Dis, 72, pp.659~664 (2013)
41. Mok CC, "Long-term immunogenicity of a quadrivalent human papillomavirus vaccine in systemic lupus erythematosus", Vaccine, 36, pp.3301~3307 (2018)
42. Soybilgic A, "Safety and immunogenicity of the quadrivalent HPV vaccine in female systemic lupus erythematosus patients aged 12to 26 years", Pediatr Rheumatol Online J, 11, pp.29~ (2013)
43. Meites E, "Human papillomavirus vaccination for adults : updated recommendations of the advisory committee on immunization practices", MMWR Morb Mortal Wkly Rep, 68, pp.698~702 (2019)

관련 논문AI추천